文献
J-GLOBAL ID:201202227791725005
整理番号:12A1651845
腫瘍壊死因子受容体関連周期性症候群に対するエタネルセプトの有効性: 前向き非盲検用量漸増試験
Efficacy of Etanercept in the Tumor Necrosis Factor Receptor-Associated Periodic Syndrome: A Prospective, Open-Label, Dose-Escalation Study
著者 (11件):
BULUA Ariel C.
(National Inst. of Arthritis and Musculoskeletal and Skin Diseases, NIH, Maryland)
,
MOGUL Douglas B.
(National Inst. of Arthritis and Musculoskeletal and Skin Diseases, NIH, Maryland)
,
AKSENTIJEVICH Ivona
(National Inst. of Arthritis and Musculoskeletal and Skin Diseases, NIH, Maryland)
,
SINGH Harjot
(National Inst. of Arthritis and Musculoskeletal and Skin Diseases, NIH, Maryland)
,
HE David Y.
(Larry R. Muenz and Associates, Maryland)
,
MUENZ Larry R.
(Larry R. Muenz and Associates, Maryland)
,
WARD Michael M.
(National Inst. of Arthritis and Musculoskeletal and Skin Diseases, NIH, Maryland)
,
YARBORO Cheryl H.
(National Inst. of Arthritis and Musculoskeletal and Skin Diseases, NIH, Maryland)
,
KASTNER Daniel L.
(National Inst. of Arthritis and Musculoskeletal and Skin Diseases, NIH, Maryland)
,
SIEGEL Richard M.
(National Inst. of Arthritis and Musculoskeletal and Skin Diseases, NIH, Maryland)
,
HULL Keith M.
(National Inst. of Arthritis and Musculoskeletal and Skin Diseases, NIH, Maryland)
資料名:
Arthritis & Rheumatism
(Arthritis & Rheumatism)
巻:
64
号:
3
ページ:
908-913
発行年:
2012年03月
JST資料番号:
C0784B
ISSN:
0004-3591
資料種別:
逐次刊行物 (A)
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)